• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

智能手表检测到多形性室性心动过速。

Polymorphic Ventricular Tachycardia Detected With a Smartwatch.

作者信息

Gu Kaien, Marshall Kirsten, Robertson-Stovel Quinn, Zieroth Shelley

机构信息

Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Section of Cardiology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

CJC Open. 2021 Dec 16;4(4):424-427. doi: 10.1016/j.cjco.2021.12.003. eCollection 2022 Apr.

DOI:10.1016/j.cjco.2021.12.003
PMID:35495853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9039566/
Abstract

"Wearable" devices are a rapidly evolving technology that often can record and store personal healthcare data. We report the case of a 64-year-old woman who presented with a syncopal episode and subsequent cardiac arrest, ultimately requiring a dual-chamber implantable cardioverter defibrillator. Prior to hospitalization, she obtained electrocardiogram recordings using her Apple Watch, due to feeling unwell, and one showed nonsustained polymorphic ventricular tachycardia. Direct-to-consumer electrocardiogram monitors in "wearables" are increasing in popularity and may play a role in the work-up and diagnosis of patients' symptoms. However, they are not a replacement for healthcare expertise, and their misuse may result in undue anxiety and inappropriate healthcare utilization.

摘要

“可穿戴”设备是一种快速发展的技术,通常能够记录和存储个人医疗保健数据。我们报告了一例64岁女性病例,该患者出现晕厥发作及随后的心脏骤停,最终需要植入双腔植入式心脏复律除颤器。在住院前,她因感觉不适,使用苹果手表获取了心电图记录,其中一份显示为非持续性多形性室性心动过速。“可穿戴”设备中的直接面向消费者的心电图监测仪越来越受欢迎,可能在患者症状的检查和诊断中发挥作用。然而,它们并不能替代医疗专业知识,其滥用可能导致过度焦虑和不适当的医疗资源利用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bf/9039566/c121ebcdba3e/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bf/9039566/1fb9c89e1fd1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bf/9039566/ce73e479c1c7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bf/9039566/c121ebcdba3e/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bf/9039566/1fb9c89e1fd1/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bf/9039566/ce73e479c1c7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76bf/9039566/c121ebcdba3e/figs1.jpg

相似文献

1
Polymorphic Ventricular Tachycardia Detected With a Smartwatch.智能手表检测到多形性室性心动过速。
CJC Open. 2021 Dec 16;4(4):424-427. doi: 10.1016/j.cjco.2021.12.003. eCollection 2022 Apr.
2
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速的除颤治疗结果
Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.
3
Consumer-facing Diagnostic Sensors in a Patient with Implantable Cardioverter-Defibrillator.植入式心脏复律除颤器患者使用的面向消费者的诊断传感器
J Innov Card Rhythm Manag. 2019 Sep 15;10(9):3822-3825. doi: 10.19102/icrm.2019.100907. eCollection 2019 Sep.
4
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.根据电击节律对植入式心脏复律除颤器和心脏再同步治疗除颤器受者电击治疗后的生存情况。节律研究中的 ALTITUDE 生存情况。
J Am Coll Cardiol. 2013 Oct 29;62(18):1674-1679. doi: 10.1016/j.jacc.2013.04.083. Epub 2013 Jun 27.
5
Cardioverter-defibrillator implantation to treat cardiac fibroma-induced ventricular tachycardia in a 70-year-old woman.植入心脏复律除颤器治疗一名70岁女性因心脏纤维瘤引起的室性心动过速。
Tex Heart Inst J. 2014 Jun 1;41(3):329-31. doi: 10.14503/THIJ-13-3270. eCollection 2014 Jun.
6
Importance of abortive shock capability with electrogram storage in cardioverter-defibrillator devices.心脏复律除颤器设备中电描记图存储的顿挫性休克能力的重要性。
J Am Coll Cardiol. 1993 Mar 15;21(4):895-900. doi: 10.1016/0735-1097(93)90344-z.
7
Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.一名患有睡眠和运动期间有症状的儿茶酚胺能多形性室性心动过速的青少年患者中一种新型兰尼碱受体2(RyR2)突变的描述:病例报告
J Med Case Rep. 2018 Oct 9;12(1):298. doi: 10.1186/s13256-018-1825-6.
8
Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.使用可穿戴式除颤器管理心脏结节病中的心脏性猝死。
PLoS One. 2018 Mar 22;13(3):e0194496. doi: 10.1371/journal.pone.0194496. eCollection 2018.
9
Failure to deliver a shock in a dual-chamber implantable cardioverter-defibrillator: a case report.
Rev Port Cardiol. 2015 Jul-Aug;34(7-8):495.e1-5. doi: 10.1016/j.repc.2014.12.008. Epub 2015 Jul 4.
10
Recurrent nocturnal ST-T deviation and nonsustained ventricular tachycardias recorded with a smartwatch: A case report.智能手表记录到的复发性夜间ST-T段偏移和非持续性室性心动过速:一例报告。
J Cardiol Cases. 2022 May 20;26(3):169-172. doi: 10.1016/j.jccase.2022.04.006. eCollection 2022 Sep.

引用本文的文献

1
Detection of Arrhythmias Using Smartwatches-A Systematic Literature Review.使用智能手表检测心律失常——一项系统文献综述
Healthcare (Basel). 2024 Apr 25;12(9):892. doi: 10.3390/healthcare12090892.
2
Smartwatch detection of new-onset monomorphic ventricular tachycardia in pregnancy.智能手表检测妊娠中新发的单形性室性心动过速。
BMJ Case Rep. 2024 Feb 19;17(2):e258807. doi: 10.1136/bcr-2023-258807.
3
The Use of Electrocardiogram Smartwatches in Patients with Cardiac Implantable Electrical Devices.心电图智能手表在植入式心脏电子设备患者中的应用。

本文引用的文献

1
Smartwatch detection of ventricular tachycardia: Case series.智能手表检测室性心动过速:病例系列
HeartRhythm Case Rep. 2020 Aug 18;6(10):800-804. doi: 10.1016/j.hrcr.2020.08.003. eCollection 2020 Oct.
2
Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation.大规模评估智能手表以识别心房颤动。
N Engl J Med. 2019 Nov 14;381(20):1909-1917. doi: 10.1056/NEJMoa1901183.
3
Wearable technology for cardiology: An update and framework for the future.可穿戴技术在心脏病学中的应用:未来的更新与框架。
Sensors (Basel). 2024 Jan 15;24(2):527. doi: 10.3390/s24020527.
Trends Cardiovasc Med. 2018 Feb;28(2):144-150. doi: 10.1016/j.tcm.2017.08.003. Epub 2017 Aug 9.
4
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.美国心力衰竭学会/美国心脏病学会/美国心脏协会关于在临床试验中未纳入或代表性不足的患者中使用植入式心脏复律除颤器治疗的专家共识声明
Circulation. 2014 Jul 1;130(1):94-125. doi: 10.1161/CIR.0000000000000056. Epub 2014 May 9.
5
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.美国心脏病学会/美国心脏协会/美国心律学会2008年心脏节律异常器械治疗指南
Heart Rhythm. 2008 Jun;5(6):e1-62. doi: 10.1016/j.hrthm.2008.04.014. Epub 2008 May 21.